Skip to content

Effects of adding Braun jejunojejunostomy to standard Whipple procedure on reduction of afferent loop syndrome- A Randomized control clinical trial .

Effects of adding Braun jejunojejunostomy to standard Whipple procedure on reduction of afferent loop syndrome- A Randomized control clinical trial .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014020316473N1
Enrollment
30
Registered
2014-02-26
Start date
2013-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Malignant neoplasm: Head of pancreas. Condition 2: Malignant neoplasm: Ampulla of Vater. Malignant neoplasm: Head of pancreas Malignant neoplasm: Ampulla of Vater

Interventions

Intervention 1: The control group will be undergone the standard Whipple procedure. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5
Treatment - Surgery
The control group will be undergone the standard Whipple procedure. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunostomy will be done 5-10 centimeter d
The intervention group will be undergone the standard Whipple procedure plus Braun jejunojejunostomy. Two layer ductojejunostomy will be used for pancreaticojejunostomy anastomosis. Choledochojejunost

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: age between 18-75 years; operability according to the preoperative imaging studies ( no invasion to portal vein, superior mesenteric artery or superior mesenteric vein, no distant metastasis, no invasion to adjacent organs); presence of pancreatic head,or duodenal, or common bile duct tumor which needs Whipple procedure Exclusion criteria: age over 75 or less than 18; death during the operation; inoperability according to any intraoperative findings

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Afferent loop syndrome. Timepoint: during the hospital stay after the thirdth day after the operation. Method of measurement: Questinaire (sudden bulky bile stained vomitus without any relation to eating).

Secondary

MeasureTime frame
Postoperative death. Timepoint: during the total hospital stay. Method of measurement: questionnaire.;Pancreatic anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (high amylase drainage from drains).;Gastric anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (low pH drainage from drains).;Biliary anastomosis leakage. Timepoint: daily till discharge. Method of measurement: questionnaire (high bilirubin drainage from drains).;Postoperative bleeding which needs another operation. Timepoint: daily till discharge. Method of measurement: questionnaire.;Postoperative gastrointestinal bleeding which needs repeat operation. Timepoint: daily till discharge. Method of measurement: questionnaire.;Surgical site infection. Timepoint: daily till discharge. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzad Kakaei

Tabriz University of Medical Sciences

fkakaei@yahoo.com+98 41 1334 1317

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 3, 2026